'Immune thrombocytopenia' diaporamas de présentation

Bleeding Disorders Haemostasis Hemorrhage in Oral Surgery

Bleeding Disorders Haemostasis Hemorrhage in Oral Surgery. What is meant by Hemorrhage ?. Prolonged or Uncontrolled Bleeding The amount of blood lost as a result of hemorrhage can range from minimal to significant quantities.

1.81k views • 72 slides

Bleeding Disorders Haemostasis Hemorrhage in Oral Surgery

Bleeding Disorders Haemostasis Hemorrhage in Oral Surgery. What is meant by Hemorrhage ?. Prolonged or Uncontrolled Bleeding The amount of blood lost as a result of hemorrhage can range from minimal to significant quantities.

2.62k views • 72 slides

Neonatal Thrombocytopenia

Neonatal Thrombocytopenia. Suzanne Reuter MD SDPA 2014 Deadwood, SD. Financial Disclosure. I have no relevant financial relationships to disclose. Objectives. Definition of thrombocytopenia Understand the pathophysiology of neonatal alloimmune thrombocytopenia

2.35k views • 56 slides

Heparin-Induced Thrombocytopenia

Heparin-Induced Thrombocytopenia. Recent Advances in Management. Heparin-induced Thrombocytopenia. Heparin-induced thrombocytopenia (HIT), an antibody-mediated syndrome, is associated with significant morbidity and mortality considered a rarity in the past unrecognized by many clinicians

1.46k views • 55 slides

In the name of God

In the name of God. Chronic ITP Presented by : F.Malek Under supervision of Dr Shamsian. A 10 year old girl known case of chronic ITP since 6 years ago which was admitted in our ward due to Epistaxis and petechia and purpura At time of admission CBC was WBC 16000 HB 12.6 Plt 9000.

599 views • 48 slides

Haematology

Haematology. Jennie Wimperis Consultant Haematologist Norfolk and Norwich University Hospital. Norwich. Immunoglobulin use in haematology 2010 database report. Total Grams Infused for Haematology in 2010. Total Grams Infused for Haematology Q1 2010.

743 views • 46 slides

Coagulation Disorders

Coagulation Disorders. Corrina Mc Mahon. Laboratory investigations. PT : VII, X, V APTT ; XII, XI, IX, VIII TT ; Fibrinogen D dimers ; fibrin breakdown. Case 1. 4 yr old boy URTI 2 weeks ago Sudden onset bruising/petechiae PH: Nil FH: Nil Physical examination:. Investigations.

521 views • 37 slides

Coagulation Disorders

Coagulation Disorders. Corrina Mc Mahon. Laboratory investigations. PT : VII, X, V APTT ; XII, XI, IX, VIII TT ; Fibrinogen D dimers ; fibrin breakdown. Case 1. 4 yr old boy URTI 2 weeks ago Sudden onset bruising/petechiae PH: Nil FH: Nil Physical examination:. Investigations.

468 views • 37 slides

ANAEMIAS

ANAEMIAS. assoc.prof. T.Datsko.

531 views • 34 slides

Thrombocytopenia in the NICU

Thrombocytopenia in the NICU. EMAD LAWENDY MD PGY2 October 2009. Aim of this PowerPoint. Discuss the incidence of neonatal thrombocytopenia. Describe the risks of a low platelet count in neonates .

460 views • 32 slides

2015 update on the pathogenesis and treatment of ITP

2015 update on the pathogenesis and treatment of ITP. Ming Hou Qilu Hospital, Shandong University. Pathogenesis. Platelet desialylation Anti-GPIb Cytotoxic T lymphocytes (CTLs) CD8 Tregs B cell depleting therapy Steroid therapy. Anti-GPIb and platelet desialylation. Background

251 views • 25 slides

IMMUNE THROMBOCYTOPENIA

498 views • 19 slides

Laboratory Management

Laboratory Management. ITP is suspected in patients with isolated thrombocytopenia Because manifestations of ITP are nonspecific, other causes of isolated thrombocytopenia need to be excluded by clinical evaluation and appropriate testing . http://www.merck.com/mmpe/sec11/ch133/ch133d.html.

332 views • 5 slides

Thrombocytopenia Treatment Market Latest Trends and Developments

Thrombocytopenia is a disorder in which a patient has low level of platelets in the blood. The major causes of thrombocytopenia are inefficient production of platelets, platelet splenic sequestration, and accelerative destruction of platelets.

42 views • 4 slides

Immune thrombocytopenia (itp) market

Global Immune Thrombocytopenia (ITP) Market: By Treatment (Intravenous immunoglobulins, Corticosteroids, Thrombopoietin receptor agonists, Others), By End-user (Hospitals and clinics, Specialty Centers, Research and Academic Institutes, others) u2014 Forecast till 2023

34 views • 3 slides